Dr. Paul Offit has argued that scientific questions should be resolved in peer-reviewed venues rather than on debate stages. In principle, I agree.
In practice, however, the public has no direct way to evaluate whether the conclusions of influential COVID-19 vaccine papers are actually supported by the underlying data and methods.
For that reason, I’m proposing a structured, public, evidence-bounded discussion focused exclusively on the published literature addressing one narrow question:
Did the mRNA COVID-19 vaccines show a clear net mortality benefit based on the studies available in the peer-reviewed literature?
Duration: 60 minutes
Scope: Peer-reviewed papers only
Preparation: Each participant submits up to three papers in advance; the reference list is shared publicly at least 14 days before the discussion
Structure:
-
Brief presentation of each paper’s claims and methods
-
Focused discussion of assumptions, bias, and interpretation
-
No appeals to authority, intent, or policy—only what the papers actually demonstrate
-
Equal talk time for both sides
The goal is not to “win” a debate, but to allow a technically literate audience to see—clearly and transparently—how different experts interpret the same published evidence.
To acknowledge the time commitment, I will make a substantial donation to a charitable organization of Dr. Offit’s choosing. The discussion, transcript, and referenced materials will be made publicly available in full.
If Dr. Offit would prefer not to participate in a direct discussion with me, I am equally open to having the discussion with another academic expert of his choosing, provided the discussion follows the same evidence-bounded format.
Given the importance of this topic to public trust in medicine, I believe a careful, transparent examination of the published literature—conducted in the open—would be of real value.
Deixe um comentário